Expert commentary from Dr. Susanna Naggie on how to manage drug–drug interactions between ART and HCV regimens during HCV/HIV coinfection.
Expert commentary from Dr. Annie Luetkemeyer on clinically relevant drug–drug interactions with direct-acting antivirals (DAAs) in PLWH
Expert commentary from Dr. Mark Sulkowski on strategies to achieve HCV elimination in persons living with HIV
Watch an HIV expert panel discuss managing HCV infection in MSM, prescribing HIV PrEP to a PWID, and managing CVD in an HIV-infected woman.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.